#United States #New Haven #Mike Waters #Wellinks #Andrew Agwunobi

Wellinks Expands Leadership Team for Enhanced Cardiopulmonary Care

Wellinks, a forefront player in virtual cardiopulmonary care, has announced significant changes in its leadership team, aiming to enrich its services and impact. The recent appointments include Dr. Andrew Agwunobi and Mike Waters to the Board of Directors, alongside three key management positions designed to bolster its operational capabilities.

New Board Members

Dr. Andrew Agwunobi

Dr. Agwunobi, boasting an extensive background in healthcare management, serves as the CEO of UConn Health. He brings a wealth of experience, having previously held pivotal roles such as President of Humana's Home Solutions unit. His varied expertise spans across health systems, government sectors, and consulting, making him a valuable asset to Wellinks particularly as it aims to expand its reach and improve patient outcomes.

Mike Waters

In tandem, Mike Waters joins the Board with over twenty years of experience in strategic operations. His tenure as Chief Operating Officer at Teladoc Health, coupled with leadership roles in Providence Health, positions him well to guide Wellinks through its next growth phase. Waters currently contributes to various digital health companies, reflecting his deep commitment to advancing healthcare technologies.

Expansion of Management Team

The management team at Wellinks has also experienced significant growth, with Stephanie Solich appointed as the new Vice President of Customer Success. Solich has dedicated over two decades to health system partnerships, focusing on client success and sustainable strategies. In her new role, she will oversee the efficacy of Wellinks' programs and ensure long-term value for clients.

Stephanie Willard, now the Vice President of Clinical Operations, previously excelled as Senior Director of Clinical Innovation at Wellinks. She will leverage her extensive experience in respiratory care to enhance clinical workflows and patient care delivery, ensuring that Wellinks remains at the cutting edge of clinical practices.

Furthermore, Andrew Brimer has been promoted to Vice President of Technology. With a solid decade in developing innovative healthcare technologies, he will spearhead initiatives aimed at evolving Wellinks' integrated care solutions.

Vision and Future Direction

Kevin Rakin, Chairman of the Board, expressed confidence in the new leadership's ability to propel Wellinks forward, stating that their combined experiences and expertise were crucial for scaling operations and enhancing the patient care model. The aim is to solidify Wellinks as a leader in cardiopulmonary care, particularly through its innovative predictive care model, which integrates clinical insights and technological advancements.

Jennifer Barretta, Wellinks' Interim CEO, emphasized the company's commitment to execution, stating, "With a strong foundation in place, our focus now is execution. I am pleased to work alongside such a passionate group of leaders whose collective expertise strengthens our ability to scale, deepen our partnerships, and extend our impact to patients and the caregivers that support them."

About Wellinks

Wellinks is reshaping the landscape of cardiopulmonary care. Their model leverages remote monitoring through the innovative Spire Remote Patient Monitoring System. This system is FDA-cleared and emphasizes data-driven insights and proactive clinical support. Wellinks focuses on reducing acute care usage and readmissions while aiming to fill care gaps experienced by individuals living with chronic conditions. To explore more about Wellinks, visit www.wellinks.com or follow them on LinkedIn for updates and insights.

With these strategic appointments and expansions in management, Wellinks stands poised to enhance its position within the healthcare market, particularly for those managing chronic cardiopulmonary issues.